These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36733175)

  • 1. [Total Pancreatectomy for Remnant Pancreatic Cancer with Positive Washing Cytology after Conversion to Negative Cytology Following Gemcitabine plus Nab-Paclitaxel Therapy-A Case Report].
    Nakajima K; Maruyama T; Aono T; Suzuki S; Kaneko K; Sato T; Okada T; Muto I; Hasegawa M; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1681-1683. PubMed ID: 36733175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conversion Surgery for Pancreatic Head Cancer with Peritoneal Dissemination Following Chemotherapy for Two Years - A Case Report].
    Hatsuzawa Y; Mizuma M; Motoi F; Hata T; Iseki M; Takadate T; Ohtsuka H; Sakata N; Morikawa T; Nakagawa K; Hayashi H; Naitoh T; Kanno A; Shimosegawa T; Unno M
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):347-349. PubMed ID: 29483443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resectable Pancreatic Cancer Successfully Treated with Neoadjuvant Chemotherapy Regimen Change to Modified FOLFIRINOX-A Case Report].
    Terao H; Maruyama T; Aono T; Suzuki S; Kaneko K; Sato T; Okada T; Muto I; Hasegawa M; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1569-1571. PubMed ID: 38303344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
    Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
    Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Conversion Surgery after Long-Term Chemotherapy for Pancreatic Cancer with Peritoneal Metastasis].
    Enoki M; Gotoh K; Sakai K; Toshiyama R; Yanagisawa K; Kawai K; Miyo M; Takahashi Y; Hamakawa T; Doi T; Takeno A; Katoh T; Takami K; Hirao M
    Gan To Kagaku Ryoho; 2023 Jan; 50(1):87-89. PubMed ID: 36759995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
    Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resection of the remnant pancreas for recurrent pancreatic cancer after distal pancreatectomy-a case report].
    Kinoshita S; Sho M; Akahori T; Nomi T; Yamato I; Hokutoh D; Yasuda S; Nakajima Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1883-5. PubMed ID: 23267918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEM + nab-PTX Therapy for Pancreatic Body Cancer cStage IVb for Conversion Surgery: A Case Report.
    Yoshii H; Izumi H; Abe R; Tajiri T; Mukai M; Nomura E; Makuuchi H
    Tokai J Exp Clin Med; 2019 Dec; 44(4):85-89. PubMed ID: 31768996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Pathological Complete Response Following Neoadjuvant Chemotherapy with Gemcitabine plus Nab-Paclitaxel in Borderline Resectable Pancreatic Cancer].
    Ohno N; Ishida M; Ohnishi K; Sawai K; Tabata S; Deguchi M; Kitajima T; Kaizaki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1735-1738. PubMed ID: 29394759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma.
    Ielpo B; Duran H; Diaz E; Fabra I; Caruso R; Ferri V; Malavé L; Hidalgo M; Alvarez R; Plaza C; Quijano Y; Vicente E
    Eur J Surg Oncol; 2016 Sep; 42(9):1394-400. PubMed ID: 26899943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report].
    Nakamoto S; Nishiyama R; Kaneda T; Yokota M; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Yamauchi H; Okuwaki K; Iwai T; Imaizumi H; Suzuki E; Hara A; Ichinoe M; Kida M; Watanabe M
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):173-176. PubMed ID: 28223678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1).
    Gao S; Zhu X; Shi X; Cao K; Bian Y; Jiang H; Wang K; Guo S; Zhang H; Jin G
    Radiat Oncol; 2019 Mar; 14(1):52. PubMed ID: 30917842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Pathological Complete Response Induced by Preoperative Chemotherapy with Gemcitabine plus Nab-Paclitaxel in a Patient with Pancreatic Cancer on Hemodialysis].
    Okazaki M; Tajima H; Ohbatake Y; Terai S; Nakanuma S; Okamoto K; Sakai S; Makino I; Kinoshita J; Nakamura K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2162-2164. PubMed ID: 30692318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact.
    Kondo N; Uemura K; Sudo T; Hashimoto Y; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S
    Eur J Cancer; 2021 Dec; 159():215-223. PubMed ID: 34781169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Re-resection for local recurrence in the remnant pancreas after pancreaticoduodenectomy for pancreatic cancer- a case report].
    Kim C; Tono T; Kimura Y; Watanabe A; Nakamura H; Inadome J; Danno K; Kagara N; Taniguchi H; Kanoh T; Ohnishi T; Nakano Y; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2448-50. PubMed ID: 22202409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma.
    Ielpo B; Caruso R; Duran H; Diaz E; Fabra I; Malavé L; Ferri V; Alvarez R; Cubillo A; Plaza C; Lazzaro S; Kalivaci D; Quijano Y; Vicente E
    Surg Oncol; 2017 Dec; 26(4):402-410. PubMed ID: 29113659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Resected Case of Adenosquamous Carcinoma of Pancreas That Relapsed in Remnant Pancreas].
    Miura K; Kanazawa A; Shimizu S; Murata A; Kodai S; Nishii T; Sakurai K; Tachimori A; Tamamori Y; Kubo N; Inoue T; Nishiguchi Y
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):524-526. PubMed ID: 29650926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.
    Aoyama T; Katayama Y; Murakawa M; Shiozawa M; Morimoto M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    Hepatogastroenterology; 2015; 62(137):200-6. PubMed ID: 25911897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three Cases of Remnant Pancreatic Cancer after Surgery for Invasive Ductal Carcinoma of Pancreas].
    Yamamoto T; Tokunou K; Kamei R; Yamamoto H; Tokuhisa A; Kitamura Y; Ando S
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1086-1088. PubMed ID: 29394542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.